Form4insider filings, from the source

Insider holders · CIK 0001583107

Theravance Biopharma, Inc. · TBPH

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
GLAXOSMITHKLINE PLC10% Owner—9,644,8079,644,807Mar 15, 2016 · 4:31 pm EDTForm 4
Eli Samaha10% Owner—9,167,4899,167,489Jul 8, 2026 · 4:13 pm EDTForm 4
Frank PasqualoneSVP, Chief Comm Ops Officer323,671—323,671Feb 22, 2019 · 6:16 pm ESTForm 4
Mathai MammenSVP, Research & Development288,111—288,111Mar 17, 2016 · 7:06 pm EDTForm 4
Philip D WorboysSVP, Translational Science270,644—270,644Feb 22, 2019 · 6:27 pm ESTForm 4
Kenneth R PitzerSVP, Prod Strat & Comm Plng266,650—266,650Feb 22, 2019 · 6:18 pm ESTForm 4
Sharathchandra S HegdeSVP, Research264,444—264,444Mar 6, 2019 · 7:20 pm ESTForm 4
Brett K HaumannSVP Clin Dev & Chief Med Ofc239,383—239,383Feb 22, 2019 · 6:13 pm ESTForm 4
Junning LeeSr. VP, Technical Operations225,0719,000234,071Feb 22, 2017 · 7:06 pm ESTForm 4
George M WhitesidesDirector192,5784,000196,578May 3, 2018 · 6:20 pm EDTForm 4
Bradford J ShaferEVP, Gen. Counsel, Secretary183,446—183,446Feb 22, 2019 · 6:22 pm ESTForm 4
Leonard M BlumSr VP, Chief Comm. Officer182,731—182,731Feb 23, 2016 · 7:56 pm ESTForm 4
Renee D GalaSVP, Chief Financial Officer157,657—157,657Nov 21, 2018 · 5:42 pm ESTForm 4
Vijay SabesanSVP, Technical Operations149,672—149,672Feb 22, 2019 · 6:20 pm ESTForm 4
Shehnaaz SulimanSVP, Corp Dev & Strategy97,198—97,198Feb 22, 2019 · 6:23 pm ESTForm 4
Ann BradyPresident, TBIL74,330—74,330Feb 22, 2019 · 6:11 pm ESTForm 4
Burton G MalkielDirector56,75715,00071,757May 23, 2018 · 6:49 pm EDTForm 4
Robert V Gunderson Jr.Director43,24510,84754,092May 3, 2018 · 6:13 pm EDTForm 4
William D YoungDirector43,310—43,310May 3, 2018 · 6:20 pm EDTForm 4
Peter S RingroseDirector29,614—29,614May 3, 2018 · 6:17 pm EDTForm 4
Susan MolineauxDirector14,18612,00026,186May 3, 2018 · 6:16 pm EDTForm 4
Eran BroshyDirector26,186—26,186May 3, 2018 · 6:11 pm EDTForm 4
Henrietta ForeDirector24,000—24,000Aug 11, 2017 · 6:33 pm EDTForm 4
Aine MillerSVP, DEV & HEAD OF IRE OFFICE0—0Sep 24, 2026 · 8:24 pm EDTForm 4
Brett A. GrimaudSVP, GEN COUNSEL AND SECRETARY0—0Sep 24, 2026 · 8:23 pm EDTForm 4
Aziz SawafSVP & CHIEF FINANCIAL OFFICER0—0Sep 24, 2026 · 8:25 pm EDTForm 4
Rhonda FarnumSVP, COMM & MEDICAL AFFAIRS0—0Sep 24, 2026 · 8:21 pm EDTForm 4
Susannah GrayDirector0—0Sep 24, 2026 · 8:31 pm EDTForm 4
Donal O'ConnorDirector0—0Sep 24, 2026 · 8:36 pm EDTForm 4
Alsup Laurie SmaldoneDirector0—0Sep 24, 2026 · 8:29 pm EDTForm 4
Rick E WinninghamCHIEF EXECUTIVE OFFICER000Sep 24, 2026 · 8:27 pm EDTForm 4
Deepika PakianathanDirector0—0Sep 24, 2026 · 8:37 pm EDTForm 4
Dean J MitchellDirector0—0Sep 24, 2026 · 8:32 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.